326 related articles for article (PubMed ID: 28882452)
1. AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy.
Morabito G; Giannelli SG; Ordazzo G; Bido S; Castoldi V; Indrigo M; Cabassi T; Cattaneo S; Luoni M; Cancellieri C; Sessa A; Bacigaluppi M; Taverna S; Leocani L; Lanciego JL; Broccoli V
Mol Ther; 2017 Dec; 25(12):2727-2742. PubMed ID: 28882452
[TBL] [Abstract][Full Text] [Related]
2. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
[TBL] [Abstract][Full Text] [Related]
3. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287
[TBL] [Abstract][Full Text] [Related]
4.
Batista AR; King OD; Reardon CP; Davis C; Shankaracharya ; Philip V; Gray-Edwards H; Aronin N; Lutz C; Landers J; Sena-Esteves M
Hum Gene Ther; 2020 Jan; 31(1-2):90-102. PubMed ID: 31696742
[TBL] [Abstract][Full Text] [Related]
5. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids.
Huang Q; Chan KY; Tobey IG; Chan YA; Poterba T; Boutros CL; Balazs AB; Daneman R; Bloom JM; Seed C; Deverman BE
PLoS One; 2019; 14(11):e0225206. PubMed ID: 31725765
[TBL] [Abstract][Full Text] [Related]
6. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
[TBL] [Abstract][Full Text] [Related]
7. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
[TBL] [Abstract][Full Text] [Related]
8. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice.
Xie BS; Wang X; Pan YH; Jiang G; Feng JF; Lin Y
Theranostics; 2021; 11(3):1177-1191. PubMed ID: 33391529
[No Abstract] [Full Text] [Related]
10. More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.
Dayton RD; Grames MS; Klein RL
Gene Ther; 2018 Aug; 25(5):392-400. PubMed ID: 30013186
[TBL] [Abstract][Full Text] [Related]
11. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia.
Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C
Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850
[TBL] [Abstract][Full Text] [Related]
12. Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice.
Davidson CD; Gibson AL; Gu T; Baxter LL; Deverman BE; Beadle K; Incao AA; Rodriguez-Gil JL; Fujiwara H; Jiang X; Chandler RJ; Ory DS; Gradinaru V; Venditti CP; Pavan WJ
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34407999
[TBL] [Abstract][Full Text] [Related]
13. Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons.
Aldrin-Kirk P; Davidsson M; Holmqvist S; Li JY; Björklund T
PLoS One; 2014; 9(7):e100869. PubMed ID: 24999658
[TBL] [Abstract][Full Text] [Related]
14. Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy.
Sargent D; Bétemps D; Drouyer M; Verchere J; Gaillard D; Arsac JN; Lakhdar L; Salvetti A; Baron T
Sci Rep; 2018 Dec; 8(1):17563. PubMed ID: 30510219
[TBL] [Abstract][Full Text] [Related]
15. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.
Chan KY; Jang MJ; Yoo BB; Greenbaum A; Ravi N; Wu WL; Sánchez-Guardado L; Lois C; Mazmanian SK; Deverman BE; Gradinaru V
Nat Neurosci; 2017 Aug; 20(8):1172-1179. PubMed ID: 28671695
[TBL] [Abstract][Full Text] [Related]
16. The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier.
Hordeaux J; Yuan Y; Clark PM; Wang Q; Martino RA; Sims JJ; Bell P; Raymond A; Stanford WL; Wilson JM
Mol Ther; 2019 May; 27(5):912-921. PubMed ID: 30819613
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 70 reduces α-synuclein-induced predegenerative neuronal dystrophy in the α-synuclein viral gene transfer rat model of Parkinson's disease.
Moloney TC; Hyland R; O'Toole D; Paucard A; Kirik D; O'Doherty A; Gorman AM; Dowd E
CNS Neurosci Ther; 2014 Jan; 20(1):50-8. PubMed ID: 24279716
[TBL] [Abstract][Full Text] [Related]
18. Effects of Neutralizing Antibody Production on AAV-PHP.B-Mediated Transduction of the Mouse Central Nervous System.
Shinohara Y; Konno A; Nitta K; Matsuzaki Y; Yasui H; Suwa J; Hiromura K; Hirai H
Mol Neurobiol; 2019 Jun; 56(6):4203-4214. PubMed ID: 30291583
[TBL] [Abstract][Full Text] [Related]
19. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection.
Huang L; Wan J; Wu Y; Tian Y; Yao Y; Yao S; Ji X; Wang S; Su Z; Xu H
Life Sci; 2021 Apr; 270():119142. PubMed ID: 33524419
[TBL] [Abstract][Full Text] [Related]
20. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
